Affordable Access

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma.

Authors
Type
Published Article
Journal
Journal of Immunotherapy
1524-9557
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
24
Issue
1
Pages
66–78
Identifiers
PMID: 11211150
Source
Medline

Abstract

Statistics

Seen <100 times